Effect of Sex Hormone-Binding Globulin on Polycystic Ovary Syndrome: Mechanisms, Manifestations, Genetics, and Treatment
Open accessThe DOI matches its Crossref record; 129 of the 129 references it cites were found in a registry or an index.
Abstract
Polycystic ovary syndrome (PCOS) is one of the most common endocrine diseases causing infertility in women of childbearing age. It is characterized by hyperandrogenemia (HA), chronic anovulation, and polycystic ovary morphology (PCOM). Most women with PCOS have metabolic abnormalities. Sex hormone-binding globulin (SHBG), a transport carrier that binds estrogen and androgens and regulates their biological activity, is usually used as an indicator of hyperandrogenism in women with PCOS. Low serum SHBG levels are considered a biomarker of metabolic abnormalities and are associated with insulin resistance (IR), HA, and abnormal glucose and lipid metabolism in PCOS patients. SHBG is also related to the long-term prognosis of PCOS, whereas SHBG gene polymorphism is associated with PCOS risk. In addition, the administration of metformin (MET), glucagon-like peptide-1 receptor agonists (GLP-1 RAs), thiazolidinediones (TZDs), compound oral contraceptives (COCs), as well as nutrient supplements such as inositol (MI), vitamin D, and synbiotics can regulate SHBG levels to ameliorate PCOS complications and improve prognosis. This review focuses on the interaction between SHBG and various PCOS complications as well as the regulation of SHBG by various drugs and nutrients and its therapeutic effects on PCOS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, increased plasma insulin levels also increase the amount of circulating free androgens by reducing the production of Sex Hormone-Binding Globulin (SHBG) in the liver [15].”
From Liraglutide and polycystic ovary syndrome: is it only a matter of body weight? (2023) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., Piltonen, T., Norman, R. J., International PCOS Network, Andersen, M., et al. (2018) · Human Reproduction · doi:10.1093/humrep/dey256 · Cited by 1,593
Adipose tissue dysfunction as determinant of obesity-associated metabolic complications
Longo, M., Zatterale, F., Naderi, J., Parrillo, L., Formisano, P., Raciti, G. A., Beguinot, F., & Miele, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092358 · Cited by 1,575
The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention
Holick, M. F. (2017) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-017-9424-1 · Cited by 1,511
Lifestyle changes in women with polycystic ovary syndrome
Lim, S. S., Hutchison, S. K., Van Ryswyk, E., Norman, R. J., Teede, H. J., & Moran, L. J. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007506.pub4 · Cited by 725
Using human genetics to understand the disease impacts of testosterone in men and women
The Endometrial Cancer Association Consortium, Ruth, K. S., Day, F. R., Tyrrell, J., Thompson, D. J., Wood, A. R., Mahajan, A., Beaumont, R. N., Wittemans, L., Martin, S., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0751-5 · Cited by 720
PLYMATE, S. R., MATEJ, L. A., JONES, R. E., & FRIEDL, K. E. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-3-460 · Cited by 693
Transcriptional regulation of hepatic lipogenesis
Wang, Y., Viscarra, J., Kim, S.-J., & Sul, H. S. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm4074 · Cited by 646
Potential role and therapeutic interests of myo-inositol in metabolic diseases
Croze, M. L., & Soulage, C. O. (2013) · Biochimie · doi:10.1016/j.biochi.2013.05.011 · Cited by 578
Research works printed but not linked: 2
- Moran, 2011, Cochrane Database Syst Rev, 2, CD007506
- Karamali, 2018, Arch Iran Med, 21, 1
Cited by
Obesity and Dyslipidemia: A Review of Current Evidence
Vekić, J., Stefanović, A., & Zeljković, A. (2023) · Current Obesity Reports · doi:10.1007/s13679-023-00518-z · Cited by 194
Mu, L., Ye, Z., Hu, J., Zhang, Y., Chen, K., Sun, H., Li, R., Mao, W., Long, X., Zhang, C., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104492 · Cited by 78
Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman
Hirschberg, A. L. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac673 · Cited by 73
Zarezadeh, M., Musazadeh, V., Faghfouri, A. H., Sarmadi, B., Jamilian, P., Jamilian, P., Tutunchi, H., & Dehghan, P. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106397 · Cited by 49
Chiang, Y., Lin, I., Huang, K., Chen, H.-Y., Ali, M. K., Huang, Y., & Hsia, S. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115327 · Cited by 48
Androgen signalling in the ovaries and endometrium
Lissaman, A. C., Girling, J. E., Cree, L. M., Campbell, R. E., & Ponnampalam, A. P. (2023) · Molecular Human Reproduction · doi:10.1093/molehr/gaad017 · Cited by 45
Hyperandrogenism and Cardiometabolic Risk in Pre- and Postmenopausal Women—What Is the Evidence?
Hirschberg, A. L. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad590 · Cited by 46
Forslund, M., Melin, J., Alesi, S., Piltonen, T., Romualdi, D., Tay, C. T., Witchel, S., Pena, A., Mousa, A., & Teede, H. (2023) · Clinical Endocrinology · doi:10.1111/cen.14913 · Cited by 32
“Importantly, COCP improves hyperandrogenism via different mechanisms, primarily by stimulation of sex hormone binding globulin (SHBG) production, the major binding protein for testosterone, thereby decreasing free circulating androgens.(10) COCP also decreases luteinizing hormone secretion, which leads to decreased ov…”
BackgroundXiong, C., Wu, J., Ma, Y., Li, N., Wang, X., Li, Y., & Ding, X. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s451129 · Cited by 37
Liraglutide and polycystic ovary syndrome: is it only a matter of body weight?
Pugliese, G., de Alteriis, G., Muscogiuri, G., Barrea, L., Verde, L., Zumbolo, F., Colao, A., & Savastano, S. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02084-6 · Cited by 29
Zhang, Y., Chen, M., Li, Y., Guo, Y., Yu, Y., Zhi, Z., Hui, L., Si, Y., Wu, C., Zhang, X., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1457467 · Cited by 31
The Interplay of Uterine Health and Obesity: A Comprehensive Review
Šišljagić, D., Blažetić, S., Heffer, M., Vranješ, M., & Müller, A. (2024) · Biomedicines · doi:10.3390/biomedicines12122801 · Cited by 33
The Ovary–Liver Axis: Molecular Science and Epidemiology
Weiskirchen, R., & Lonardo, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136382 · Cited by 24
Eini, F., Azizi, M., Foroutan, T., & Salehi, E. (2022) · BMC Molecular and Cell Biology · doi:10.1186/s12860-022-00449-y · Cited by 22
Chavez, G. N., Jaworsky, K., & Basu, A. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20156534 · Cited by 26
Effects of distinct Polycystic Ovary Syndrome phenotypes on bone health
Mills, E., Abbara, A., Dhillo, W. S., & Comninos, A. N. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1163771 · Cited by 19
Diagnostic and prognostic biomarkers in Polycystic Ovary Syndrome
Singh, I., Moar, K., & Maurya, P. K. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120425 · Cited by 25
Abubakar, M., Saleem, A., Hajjaj, M., Faiz, H., Pragya, A., Jamil, R., Salim, S. S., Lateef, I. K., Singla, D. K., Ramar, R., et al. (2023) · Heart Failure Reviews · doi:10.1007/s10741-023-10369-4 · Cited by 17
Taha, B. A., Al-Rawi, M. A., Addie, A. J., Abdulateef, S. A., Haider, A. J., Chaudhary, V., & Arsad, N. (2025) · Microchimica Acta · doi:10.1007/s00604-025-07415-3 · Cited by 17
Hoteit, B. H., Kotaich, J., Ftouni, H., Hazime, F., Safawi, A., Masri, R., & Marwani, M. (2025) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188251383064 · Cited by 21
Understanding hirsutism in PCOS
Oliveira, T. F., & Comim, F. V. (2024) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2024.2310558 · Cited by 20
Beyond counting sheep: Exploring the link between polycystic ovary syndrome and sleep health
Jafar, N. K. A., Bennett, C. J., Moran, L. J., & Mansfield, D. R. (2023) · Seminars in Reproductive Medicine · doi:10.1055/s-0043-1777724 · Cited by 12
Voros, C., Papadimas, G. K., Mavrogianni, D., Koulakmanidis, A.-M., Athanasiou, D., Bananis, K., Athanasiou, A. I., Athanasiou, A. V., Papapanagiotou, I., Vaitsis, D., et al. (2025) · Genes · doi:10.3390/genes16091101 · Cited by 16
Jafar, N. K. A., Fan, M., Moran, L., Mansfield, D. R., & Bennett, C. (2025) · Clinical Endocrinology · doi:10.1111/cen.15219 · Cited by 18
Bourebaba, L., Kępska, M., Qasem, B., Zyzak, M., Łyczko, J., Klemens, M., Mularczyk, M., & Marycz, K. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1214961 · Cited by 14
Zhang, X., Miao, H., Zhou, J., Chen, Y., Ou, Y., Song, Y., Peng, X., Li, Y., & Li, L. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1109861 · Cited by 12
Roy, M., Parveen, R., Khan, P. M., Majid, H., Pathak, M., Saxena, R. K., & Agarwal, N. B. (2024) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2024.2407513 · Cited by 11
Chen, Q., Tao, Q., Qilin, Z., Zhu, J., & Du, X. (2023) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s423177 · Cited by 12
Metabolic Syndrome, Hepatic Steatosis and Testosterone: A Matter of Sex
Gangitano, E., Scannapieco, F., Lubrano, C., & Gnessi, L. (2024) · Livers · doi:10.3390/livers4040038 · Cited by 11
Dharani, V., Nishu, S., & Lakshmanan, H. (2025) · Reproductive Biology · doi:10.1016/j.repbio.2025.101017 · Cited by 11
Nanoparticles in Hormonal Regulation of the Female Reproductive System
Vijayakumar, V., Rathinam, T., Deenadhayalan, S. S., Edwin, E. R., Harikrishnan, P., & Balaji, P. (2024) · Journal of Bio-X Research · doi:10.34133/jbioxresearch.0027 · Cited by 14
Yadav, S., Dadge, S. D., Garg, R., Goand, U. K., Agarwal, A. K., Chauhan, D., & Gayen, J. R. (2024) · Steroids · doi:10.1016/j.steroids.2024.109558 · Cited by 8
Tătaru, I., Gardikiotis, I., Dragostin, O.-M., Confederat, L. G., Gîrd, C. E., Zamfir, A.-S., Morariu, I. D., Chițescu, C. L., Dinu, A., Popescu, L. C., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13040922 · Cited by 9
Nandi, A., Singh, K. D., & Sharma, K. (2025) · Microchimica Acta · doi:10.1007/s00604-025-07187-w · Cited by 13
van Bree, B. E., van der Heijden, D. M. B., van Golde, R. J. T., Brouwers, M. C. G. J., Spaanderman, M. E. A., & Valkenburg, O. (2025) · Gynecological Endocrinology · doi:10.1080/09513590.2025.2500462 · Cited by 8
Alshammary, A. F., Alshammari, A., Farzan, R. A., Alsobaie, S. F., Alageel, A. A., & Khan, I. A. (2023) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2023.103687 · Cited by 8
Oxidative Stress in Polycystic Ovary Syndrome: Impact of Combined Oral Contraceptives
Santander, N. G., Figueroa, E. G., González‐Candia, A., Maliqueo, M. A., Echiburú, B., Crisosto, N., & Salas‐Pérez, F. (2024) · Antioxidants · doi:10.3390/antiox13101168 · Cited by 10
Kogure, G. S., Ribeiro, V. B., Mendes, M. C., Ferriani, R. A., Furtado, C. L. M., & dos Reis, R. M. (2023) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000627 · Cited by 8
Unraveling PCOS therapies: Pharmacotherapeutic strategies and emerging therapeutic targets
Shirasath, K. R., Ahmed, N. Z., Kumar, P., Alam, S., Karwasra, R., Goyal, S. N., & Agrawal, Y. O. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156245 · Cited by 7
Phytotherapy in Polycystic Ovary Syndrome (PCOS) Management: A Systematic Review
Mohamed, S. S., Allam, A. T., Elalfy, A., El‐Shiekh, R. A., Reda, A. M., & Hafeez, M. S. A. E. (2025) · Chemistry & Biodiversity · doi:10.1002/cbdv.202500982 · Cited by 6
Burns, K. A., Stuckey, A. W., Wilson, S. G., Watts, G. F., & Stuckey, B. G. A. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1572427 · Cited by 8
Healy, R., Patten, R. K., Bauer, C., Woessner, M. N., Bourke, M., Grossmann, M., & Levinger, I. (2024) · Sports Medicine - Open · doi:10.1186/s40798-024-00781-x · Cited by 8
Cela, E., Alcubierre, D. D., & Sbardella, E. (2024) · Clinical Endocrinology · doi:10.1111/cen.15182 · Cited by 10
Analyzing the Challenges, Consequences, and Possible Treatments for Polycystic Ovary Syndrome
Zaib, S., Rana, N., Khan, I. A., Waris, A., & Ahmad, U. (2023) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557523666230608124651 · Cited by 9
Tűű, L., Nas, K., Török, M., & Várbíró, S. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13030838 · Cited by 8
Ji, E., Wang, Z., Zhong, R., Lu, Y., Zheng, R., Ning, S., Hu, M., Li, J., Lai, M., Xue, G., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf276 · Cited by 4
Patni, M. A., Dube, R., Kar, S. S., George, B. T., Goud, M., Srinivasamurthy, S. K., & Elamin, A. A. E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125575 · Cited by 9
Al-Enazi, A. M. M., Virk, P., Almoqhem, R., Alsharidah, A. R., Al‐Ghadi, M. Q., Aljabr, W. A., Alasmari, F. F., & Albasher, G. I. (2024) · Biomedicines · doi:10.3390/biomedicines12050943 · Cited by 5
Kazeminia, M., Rajati, F., Rasulehvandi, R., & Rajati, M. (2024) · Middle East Fertility Society Journal · doi:10.1186/s43043-024-00201-w · Cited by 12
Navigating the Future of PCOS Treatment: The Precision Medicine Paradigm
Sunil, A. T., Jo, C., Sanigha, P. S., Kolasseri, A. E., Tamizhselvi, R., & Jayanthi, S. (2024) · Current pharmacogenomics and personalized medicine (Online)/Current pharmacogenomics and personalized medicine · doi:10.2174/0118756921331801240820115132 · Cited by 6
Hestiantoro, A., Saraswati, J., Prasetya, D. E., Sandra, F., Muharam, R., Pratama, G., & Harzif, A. K. (2024) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v16i1.2639 · Cited by 3
Yang, W., Yin, L., Xie, Q., Tan, M., Liu, Y., Xu, J., & Wu, J. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1699600 · Cited by 3
Shlyakhto, E. V., Dedov, I. I., Serov, V. N., Sukhikh, G. T., Arutyunov, G. P., Suchkov, I. A., Drapkina, O. M., Tkacheva, O. N., Orlova, Y. A., Baranov, I. A., et al. (2026) · Problems of Endocrinology · doi:10.14341/probl13694 · Cited by 3
Xu, J., & He, B. (2026) · Journal of Ovarian Research · doi:10.1186/s13048-026-02124-8 · Cited by 2
Self-citationAndrogens and Hirsutism in a Large Cohort of Portuguese Women
Pinto, J., Cera, N., Camerino, C., Beires, J., & Pignatelli, D. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14030673 · Cited by 6
Kumar, N., Sharma, N., Roy, S. D., Chawla, I., & Sharma, L. K. (2025) · Advanced Biomedical Research · doi:10.4103/abr.abr_262_23 · Cited by 5
Parahuleva, N., Mihaylova, A., Harizanova, S. N., Merdzhanova-Gargova, Y., Koleva, M., Madzharov, V. G., Strikova, G., & Uchikova, E. H. (2025) · Healthcare · doi:10.3390/healthcare13080884 · Cited by 6
Therapeutic Targets and Drug Leads for Reproductive Health
Premrajan, P., & Variyar, E. J. (2024) · Springer eBooks · doi:10.1007/978-981-99-9183-9_18 · Cited by 3
Assessing the Effects of Metformin on Lipid Metabolism in Women with PCOS
Afridi, S., Saifullah, S., Falah, S. F., Naz, F., Ahmad, S., & Shaukat, A. (2025) · Pakistan Journal of Health Sciences · doi:10.54393/pjhs.v6i5.2980 · Cited by 3
A Complex Condition; Polycystic Ovary Syndrome (PCOS): A Review of its Recent Advanced Treatment
Wal, P., Saxena, B., Aziz, N., Pyne, C., Wal, A., & Rathore, S. (2023) · Current Women s Health Reviews · doi:10.2174/0115734048259334231020120628 · Cited by 2
Research progress on insulin resistance in polycystic ovary syndrome
Qi, Y.-B., Yi, P., & Fu, X. (2025) · Reproductive and Developmental Medicine · doi:10.1097/rd9.0000000000000131 · Cited by 5
Nandi, A., Gillespie, S. W., Ice, S. N., Thakur, D., Gaur, Y. K., Singh, K. D., & Sharma, K. (2025) · Biosensors and Bioelectronics X · doi:10.1016/j.biosx.2025.100657 · Cited by 5
Clinical utility of FAI and SHBG in differentiating PCOS from anovulatory cycles in adolescent girls
Özer, E., Taş, D., Gündoğan, S. Ç., Boyraz, M., & GÜRBÜZ, F. (2025) · Frontiers in Pediatrics · doi:10.3389/fped.2025.1581060 · Cited by 4
Dürgen, P., Wölfle, P. J., Ceglarek, U., Kratzsch, J., Kieß, W., & Vogel, M. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120621 · Cited by 2
Cooper, I. D., Petagine, L., Soto-Mota, A., Duraj, T., Seyfried, T. N., Lee, D. C., Cooper, N., & Kyriakidou, Y. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1731915 · Cited by 2
Ren, Z., Cheng, X., Xu, J., Niu, T., & Long, H. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1297213 · Cited by 2
Muarrofah, M., Santoso, B., & Tirthaningsih, I. W. (2023) · Bali Medical Journal · doi:10.15562/bmj.v12i3.4757 · Cited by 2
Multimorbidität bei endokrinologischen Erkrankungen: Klinische Implikationen des PCOS
Arjune, S., Bollheimer, C., & Hanßen, R. (2025) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-2365-9507 · Cited by 2
Extracellular fluid miRNAs in PCOS
Hadi, S., Khoshraftar, S. H., Darabi, A. H. K., Soleimani, A., & Nejabati, H. R. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120404 · Cited by 2
Diagnostic value of anti-Mullerian hormone in adolescent girls with polycystic ovary syndrome
Sorokman, Т. V., Makarova, O. V., & Ostapchuk, V. G. (2022) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.18.3.2022.1164 · Cited by 2
Abd-Alqader, S. M., Zearah, S. A., & Alassadi, I. J. (2023) · Baghdad Science Journal · doi:10.21123/bsj.2023.8187 · Cited by 4
Upadhyay, S., Mazumder, A., & Das, S. (2025) · Current Pharmaceutical Design · doi:10.2174/0113816128382284250822045319 · Cited by 1
Impact of substance abuse on polycystic ovarian syndrome
Ajayi, L. O., Onaolapo, M. C., Akanbi, G. B., Ayodele, A. H., Alabi, M. O., Gbenga, G. O., Akano, O. P., & Ajayi, A. F. (2025) · Discover Endocrinology and Metabolism · doi:10.1007/s44417-025-00004-1 · Cited by 1
Abduljabbar, H., Jamal, M., & Esmat, A. (2026) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010433981251031050335 · Cited by 1
Thomas, S. M., Ajay, N., Kandasamy, V., & Veerabathiran, R. (2026) · Annals of Medicine · doi:10.1080/07853890.2026.2688583 · Cited by 1
Thirumurugan, A., Ravi, S., & Annamalai, A. (2026) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2026.107088 · Cited by 3
Zahra, A. T., Saleh, M. M. I., Hafy, Z., Effendi, Y., Maritska, Z., & Liberty, I. A. (2023) · Biomedika · doi:10.23917/biomedika.v15i1.1744 · Cited by 4
The Role of Testosterone Level in Women with Osteopenia
Taha, M. M., Taha, E. M., & Mohammed, S. K. (2023) · Baghdad Science Journal · doi:10.21123/bsj.2023.8140 · Cited by 5
Ивановна, А. Е., Yarmolinskaya, M. I., & Osinovskaya, N. S. (2023) · Journal of obstetrics and women s diseases · doi:10.17816/jowd611015 · Cited by 2
Zhao, Q., Velu, P., Prabahar, K., Hernández‐Wolters, B., & Zhi, Q. D. (2025) · Hormone and Metabolic Research · doi:10.1055/a-2531-9363 · Cited by 1
Özer, E., Taş, D., Gündoğan, S. Ç., Boyraz, M., & GÜRBÜZ, F. (2024) · Research Square · doi:10.21203/rs.3.rs-4945396/v1 · Cited by 1
Tirotoksikozun Nadir Bir Nedeni: TSH Salgılayan Hipofiz Adenomu
Çalapkulu, M., Sencar, M. E., Ünsal, İ. Ö., Kayıhan, S., Kızılgül, M., Özbek, M., Kertmen, H., & ÇAKAL, E. (2022) · Uludağ Üniversitesi Tıp Fakültesi Dergisi · doi:10.32708/uutfd.1160463
ROLE OF SEX HORMONE BINDING GLOBULIN AS AN INDICATOR OF INSULIN RESISTANCE
Hussain, N., Munir, M. U., Khan, M. Q. A., Haroon, Z. H., & Younas, M. (2023) · Pakistan Journal of Pathology · doi:10.55629/pakjpathol.v34i1.747
Relationships between nonalcoholic fatty liver disease and polycystic ovary syndrome
Манжалій, Е., Татарчук, Т. Ф., Tutchenko, T. М., Косей, Н. В., & Mnevets, R. O. (2023) · Reproductive Endocrinology · doi:10.18370/2309-4117.2023.70.40-45 · Cited by 3
Einführung: Wirkungen und Stoffwechsel der praxisrelevanten Hormongruppen
Gudermann, T. W., & Boekhoff, I. (2024) · Springer eBooks · doi:10.1007/978-3-662-65517-7_1
Binobead, M. A., Abualamah, S. M., Alshuniaber, M. A., AlSedairy, S. A., Alhussain, M. H., Albadr, N. A., & Arzoo, S. (2024) · American Journal of Health Behavior · doi:10.5993/ajhb.48.4.22
Ou, Y., Li, Y., Zhang, X., Liu, X., Wen, X., Liang, Y., & Wang, Q. (2024) · Research Square · doi:10.21203/rs.3.rs-5032941/v1
Panda, S., Jyothi, K., Konar, L., & Hussain, Z. (2025) · Obstetrics and gynecology. · doi:10.5772/intechopen.1011570 · Cited by 2
Devalla, A. V., Srirambhatla, A., Muddam, B., Tikka, S. K., & Mangla, M. (2025) · The Egyptian Journal of Radiology and Nuclear Medicine · doi:10.1186/s43055-025-01578-y
Shlyakhto, E. V., Dedov, I. I., Serov, V. N., Sukhikh, G. T., Arutyunov, G. P., Suchkov, I. A., Drapkina, O. M., Tkacheva, O. N., Orlova, Y. A., Baranov, I. A., et al. (2025) · Kardiologiia · doi:10.18087/cardio.2025.11.n3056 · Cited by 1
Liu, X., Ren, J., Cheng, Y., & Liu, Y. (2026) · Cytotechnology · doi:10.1007/s10616-026-00904-0
Zhu, R. Y., Wang, X., Ma, J., Shi, X., Zhang, Y., Jin, J., & Zhou, H. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1598164
Mécanismes d'action de l'Œstradiol dans l'ovaire humain en conditions physiologique et polykystique
Marie, C. (2024) · theses.fr (ABES) · doi:10.70675/1310af87z3c5ez4c52zad31z9af8ec853cee
Hyperandrogenism in dermatology: pathogenesis, diagnosis, and treatment
Zybareva, A., Perlamutrov, Y. N., & Klyuchnikova, D. (2026) · Russian Journal of Skin and Venereal Diseases · doi:10.17816/dv701286
Shlyakhto, E. V., Dedov, I. I., Serov, V. N., Sukhikh, G. T., Arutyunov, G. P., Suchkov, I. A., Drapkina, O. M., Tkacheva, O. N., Orlova, Y. A., Baranov, I. A., et al. (2026) · Bulletin of Reproductive Health · doi:10.14341/brh12788
Heidari, Z., Moradi, L., Farhangiyan, Z., Zakerkish, M., & Mansoori, A. (2026) · Journal of Functional Foods · doi:10.1016/j.jff.2026.107316
He, Y., Li, J., Qiu, J., & Shi, Q. (2026) · International Journal of Impotence Research · doi:10.1038/s41443-026-01283-y
Bhattacharyya, S., Barik, S., Gupta, S., Goswami, U., Samashaptak, F., & Saha, S. (2026) · Indian Journal of Perinatology and Reproductive Biology · doi:10.5005/ijoparb-11057-0015
Wang, X., (301752), K. Z., Hao, J., Zhao, M., Wang, X., & Xu, L. (2026) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2026.112836
Metadata
- Authors
- Xing, C., Zhang, J., Zhao, H., & He, B.
- Affiliations
- Sheng Jing Hospital (CN)
- Corresponding author
- He, Bing
- Venue
- International Journal of Women's Health
- Publisher
- Informa UK Limited
- Published
- 2022-02
- Volume
- Volume 14
- Pages
- 91-105
- ISSN
- 1179-1411 (ISSN-L)
- PMC
- PMC8818772
- OpenAlex
- W4210722375
- Cited by
- 118
- References
- 126
- Citations by year
- 2026: 33 · 2025: 31 · 2024: 23 · 2023: 26 · 2022: 5
- FWCI
- 3.42
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Women s Health (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Funders
- National Natural Science Foundation of China (81570765)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Keywords
- polycystic ovary syndrome, sex hormone-binding globulin, hyperandrogenemia, insulin resistance, metabolic abnormalities, metformin, GLP-1 receptor agonists, thiazolidinediones, oral contraceptives, myo-inositol, vitamin D, synbiotics, PCOS treatment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.